[1P-298] Roles of aldo-keto reductase 1C3, MAP kinase and Akt in development of cisplatin resistance in breast cancer cells in the presence of estrogen

Yukino Nagao¹, Yuji Sakai², Yoshifumi Morikawa², Aki Hisamatsu³, Kazuhiro Iguchi⁴, ^〇Toshiyuki Matsunaga^1,3 (1.Laboratory of Bioinformatics, Gifu Pharmaceutical University, 2.Forensic Science Laboratory, Gifu Prefectural Police Headquarters, 3.Education Center of Green Pharmaceutical Sciences, Gifu Pharmaceutical University, 4.Laboratory of Community Pharmacy, Gifu Pharmaceutical University)

キーテクノロジー：細胞毒性試験

アルドケト還元酵素1C3、シスプラチン、乳がん、MAPキナーゼ、Akt